Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000924930 | SCV001070457 | likely benign | not provided | 2024-07-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002495551 | SCV002800487 | likely benign | Age related macular degeneration 9; Atypical hemolytic-uremic syndrome with C3 anomaly; Complement component 3 deficiency | 2021-11-29 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003960434 | SCV004772690 | likely benign | C3-related disorder | 2019-07-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |